hsa05200: Pathways in cancer |
3 |
0.029 |
VEGFB, WNT5B, FN1 |
hsa04120: Ubiquitin mediated proteolysis |
2 |
0.032 |
NEDD4, UBE2S |
hsa00230: Purine metabolism |
2 |
0.039 |
PDE7B, POLA2 |
hsa05205: Proteoglycans in cancer |
2 |
0.043 |
WNT5B, FN1 |
hsa04510: Focal adhesion |
2 |
0.044 |
VEGFB, FN1 |
hsa01100: Metabolic pathways |
5 |
0.044 |
MAN2A1, TDO2, B4GALT3, CTPS2, POLA2 |
hsa04810: Regulation of actin cytoskeleton |
2 |
0.045 |
GSN, FN1 |
hsa04014: Ras signaling pathway |
2 |
0.047 |
VEGFB, RIN1 |
hsa04060: Cytokine-cytokine receptor interaction |
2 |
0.047 |
VEGFB, CXCL14 |